Elsevier

Preventive Medicine

Volume 14, Issue 3, May 1985, Pages 293-311
Preventive Medicine

Coronary heart disease and all-causes mortality in the multiple risk factor intervention trial: Subgroup findings and comparisons with other trials

https://doi.org/10.1016/0091-7435(85)90058-1Get rights and content

Abstract

The Multiple Risk Factor Intervention Trial (MRFIT) was a randomized primary prevention trial to test whether a special intervention (SI) program to reduce high blood pressure, elevated blood cholesterol, and/or cigarette smoking could lower coronary heart disease (CHD) mortality in middle-aged men at above average risk. After an average follow-up period of 7 years, risk factor levels were reduced substantially more in SI than in usual-care (UC) men; however, SI-UC differences in CHD mortality (7.1%) and total mortality (−2.1%) were not statistically significant. Subgroup analysis showed 35% fewer SI than UC CHD deaths (P = 0.14) but no all-causes mortality difference in men comparable to the cohort having dietary and smoking intervention in Oslo (the “Oslo-like” cohort). Among the subgroup hypertensive at entry, SI-UC differences in CHD and total mortality appeared to be heterogeneous: CHD mortality was 24% lower in SI than UC men with a normal resting ECG at baseline, but 67% higher if baseline ECG abnormalities were present (nominal P = 0.02, for difference in relative risk estimates). These findings were supported by within-group analyses and are generally consistent with results of other CHD/cardiovascular disease prevention trials. They pose a new hypothesis about possible adverse effects of diuretic therapy in a minority of the hypertensive population.

References (30)

  • L. Holme et al.

    Treatment of mild hypertension with diuretics: The importance of ECG abnormalities in the Oslo Study and in MRFIT

    JAMA

    (1984)
  • Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension

    JAMA

    (1979)
  • The effect of treatment on mortality in “mild” hypertension—Results of the Hypertension Detection and Follow-up Program

    New Engl. J. Med.

    (1982)
  • The effect of antihypertensive drug treatment on mortality in the presence of resting ECG abnormalities at baseline: The HDFP experience

    Circulation

    (1984)
  • P. Leren et al.

    The Oslo Study, cardiovascular disease in middle-aged and young Oslo men

    Acta Med. Scand. Suppl.

    (1975)
  • Cited by (28)

    • A review of research on cigarette smoking in Preventive Medicine in recognition of the journal's 50th anniversary

      2022, Preventive Medicine
      Citation Excerpt :

      The mean RCR for the 106 articles meeting eligibility criteria was 1.67 (±0.14), which is at the 69th normalized percentile; 64 of these 106 articles (60.38%) had an RCR that exceeded the NIH median 1.0 and 50th normalized percentile, supporting greater that average influence for NIH-supported research in this field (Table 1). These 64 higher impact studies included a body of controlled trials examining innovative psychosocial interventions to promote smoking cessation as part of interventions to reduce multiple risk behaviors in adults with cardiovascular and other smoking-related medical problems (e.g., Cutler et al., 1985; Holme et al., 1985; Orleans et al., 1990) and interventions focused exclusively on smoking cessation during or following medical treatment for other conditions (Dornelas et al., 2000; Hennrikus et al., 2005; Virtanen et al., 2015). Another body of research focused on improving cessation rates among pregnant women including innovations around the use of financial incentives (e.g., Secker-Walker et al., 1998; Ferreira-Borges, 2005; Higgins et al., 2014; Kurti et al., 2020).

    View all citing articles on Scopus
    View full text